John Feller, MD, Founding Partner and Medical Director at Desert Medical Imaging, gives an overview of radiogenomics’ current and possible future role in prostate cancer care. He notes the recent promising results of multiparametric MRI (mpMRI) from trials, which have shown that using mpMRI before transrectal ultrasound-guided (TRUS) biopsy can decrease the number of unnecessary biopsies, limit detection of insignificant cancer, and improve detection of significant cancer. These have influenced the updated 2019 National Comprehensive Cancer Network (NCCN) Guidelines for prostate cancer. Dr. Feller further discusses other biomarkers for risk stratification and promising research on radiogenomics in the setting of focal therapy.Read More
John Feller, MD
Desert Medical Imaging
Palm Desert, California
John Feller, MD, graduated from the Ohio State University School of Medicine, completed postgraduate training at Stanford University, and is board-certified in Diagnostic Radiology. He served in the Air Force as Chief of MRI at the David Grant Medical Center. He was previously Assistant Clinical Professor for the Stanford Department of Radiology, where he was awarded Volunteer Clinical Faculty Teacher of the Year. He has given 400+ lectures worldwide, co-authored numerous peer-reviewed articles and book chapters, and is editor of the textbook Shoulder Magnetic Resonance Imaging. Dr. Feller leads an MRI-based prostate cancer detection and treatment program through Desert Medical Imaging, providing care to 3,000+ patients.